3 ASX Penny Stocks With Market Caps Under A$2B To Consider
Top 10 Penny Stocks In Australia
Name
Share Price
Market Cap
Financial Health Rating
Alfabs Australia (ASX:AAL)
A$0.40
A$114.64M
★★★★☆☆
EZZ Life Science Holdings (ASX:EZZ)
A$2.18
A$102.84M
★★★★★★
GTN (ASX:GTN)
A$0.575
A$109.63M
★★★★★★
IVE Group (ASX:IGL)
A$2.94
A$453.29M
★★★★★☆
West African Resources (ASX:WAF)
A$2.30
A$2.62B
★★★★★★
Southern Cross Electrical Engineering (ASX:SXE)
A$1.76
A$465.36M
★★★★★★
Regal Partners (ASX:RPL)
A$3.01
A$1.01B
★★★★★★
Sugar Terminals (NSX:SUG)
A$0.99
A$360M
★★★★★★
Bisalloy Steel Group (ASX:BIS)
A$4.01
A$190.27M
★★★★★★
CTI Logistics (ASX:CLX)
A$1.84
A$148.2M
★★★★☆☆
Click here to see the full list of 463 stocks from our ASX Penny Stocks screener.
Let's dive into some prime choices out of the screener.
BKI Investment
Simply Wall St Financial Health Rating: ★★★★★☆
Overview: BKI Investment Company Limited is a publicly owned investment manager with a market cap of A$1.47 billion.
Operations: The company generates revenue of A$69.33 million from the securities industry.
Market Cap: A$1.47B
BKI Investment Company Limited, with a market cap of A$1.47 billion, reported revenue of A$69.33 million for FY2025, showing slight growth from the previous year. Despite being debt-free for five years and maintaining high-quality earnings, BKI's net income declined to A$61.86 million from A$64.39 million last year, with a lower net profit margin of 89.2%. The company's dividend yield is 4.34%, but it's not well covered by earnings or free cash flows, raising sustainability concerns despite experienced board oversight and stable weekly volatility at 1%.
Jump into the full analysis health report here for a deeper understanding of BKI Investment.
Evaluate BKI Investment's historical performance by accessing our past performance report.
Helloworld Travel
Simply Wall St Financial Health Rating: ★★★★★★
Overview: Helloworld Travel Limited is a travel distribution company operating in Australia, New Zealand, and internationally with a market cap of A$270.47 million.
Operations: The company's revenue is primarily generated from Travel Operations in Australia (A$153.71 million), New Zealand (A$36.06 million), and the Rest of World (A$3.72 million), along with contributions from Transport, Logistics, and Warehousing (A$15.20 million).
Market Cap: A$270.47M
Helloworld Travel Limited, with a market cap of A$270.47 million, has been involved in merger discussions with Webjet Group and BGH Capital, potentially leading to a strategic consolidation. Despite recent negative earnings growth of -22.9%, Helloworld has maintained profitability over the past five years and is debt-free, offering financial stability. The company's short-term assets exceed its liabilities, but its 6.65% dividend isn't well covered by free cash flows, posing sustainability questions. Trading at a price-to-earnings ratio of 10.4x below the Australian market average suggests it might offer value compared to peers despite current challenges in earnings growth and profit margins declining from last year's levels.
Click to explore a detailed breakdown of our findings in Helloworld Travel's financial health report.
Gain insights into Helloworld Travel's future direction by reviewing our growth report.
PharmX Technologies
Simply Wall St Financial Health Rating: ★★★★★★
Overview: PharmX Technologies Limited is a technology and software development company operating in Australia with a market cap of A$71.82 million.
Operations: PharmX Technologies generates revenue primarily from its Health Services segment, which accounted for A$7.07 million.
Market Cap: A$71.82M
PharmX Technologies, with a market cap of A$71.82 million, primarily generates revenue from its Health Services segment (A$7.07 million). The company is debt-free, eliminating interest payment concerns and demonstrating financial stability with short-term assets (A$5.7M) surpassing liabilities (A$1.1M). Despite negative earnings growth (-94.7%) over the past year and low return on equity (0.09%), PharmX has avoided shareholder dilution recently and maintains an experienced management team with a 2.8-year average tenure. However, profit margins have declined to 0.2% from last year's 4.2%, indicating challenges in maintaining profitability amidst industry pressures.
Take a closer look at PharmX Technologies' potential here in our financial health report.
Assess PharmX Technologies' previous results with our detailed historical performance reports.
Key Takeaways
Click through to start exploring the rest of the 460 ASX Penny Stocks now.
Seeking Other Investments? This technology could replace computers: discover the 26 stocks are working to make quantum computing a reality.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Companies discussed in this article include ASX:BKI ASX:HLO and ASX:PHX.
This article was originally published by Simply Wall St.
Have feedback on this article? Concerned about the content? with us directly. Alternatively, email editorial-team@simplywallst.com
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
CNBC
2 hours ago
- CNBC
Dollar holds losses on U.S. economy concerns, Fed appointments
The dollar remained lower against major peers on Thursday, as expectations of Federal Reserve rate cuts grew and concerns swirled about partisanship creeping into key U.S. institutions. Initial jobless claims in the United States are under scrutiny after last week's disappointing nonfarm payrolls, which triggered a slide in the greenback. Meanwhile, the euro found support ahead of anticipated talks next week to end the war between Russia and Ukraine. Last week, President Donald Trump fired the official responsible for the labour data he did not like, and focus is centring on his nomination to fill a coming vacancy on the Fed's Board of Governors and candidates for the next chair of the central bank. "All those things suggest that we're seeing those political risks around the U.S. dollar increase, and on top of that you've got the weak data coming through," said Tony Sycamore, a market analyst at IG. Any progress in ending the war in Ukraine "is going to be a positive driver of the euro," he added. The dollar index, which measures the greenback against a basket of major peers, edged up 0.1% to 98.259 in early trade in Asia, after a 0.6% slide in the previous session. The U.S. currency was little changed at 147.36 yen. The euro stood at $1.1654, down almost 0.1% after a 0.7% jump previously. The U.S. Labor Department is expected to report that initial claims for unemployment benefits likely rose by 3,000 to 221,000 for the week ended August 2. Continued jobless claims for the week that ended July 26 are expected to increase slightly. Data last Friday showed U.S. employment growth was weaker than expected in July while the nonfarm payrolls count for the prior two months was revised down considerably, suggesting a sharp deterioration in labour market conditions. Fed funds futures traders are now pricing in a 94% probability of a 25 basis point cut at the Fed's September meeting, up from 48% a week ago, according to the CME Group's FedWatch Tool. In total, traders see 60.5 basis points in cuts this year. Trump could meet Russian leader Vladimir Putin as soon as next week, a White House official said on Wednesday, as the U.S. kept up pressure on Moscow to end the war in Ukraine. The president said on Tuesday he would decide on a nominee to replace outgoing Fed Governor Adriana Kugler by the end of the week and had separately narrowed the possible replacements for Fed Chair Jerome Powell to a short list of four. Sterling was steady at $1.33505. The Australian dollar was little changed at $0.65. Bitcoin edged 0.1% lower to $115,038.79.
Yahoo
2 hours ago
- Yahoo
Private equity firms account for 35% of ClearView Wealth Limited's (ASX:CVW) ownership, while individual investors account for 32%
Key Insights The considerable ownership by private equity firms in ClearView Wealth indicates that they collectively have a greater say in management and business strategy The top 2 shareholders own 51% of the company Institutions own 26% of ClearView Wealth Trump has pledged to "unleash" American oil and gas and these 15 US stocks have developments that are poised to benefit. A look at the shareholders of ClearView Wealth Limited (ASX:CVW) can tell us which group is most powerful. And the group that holds the biggest piece of the pie are private equity firms with 35% ownership. In other words, the group stands to gain the most (or lose the most) from their investment into the company. Meanwhile, individual investors make up 32% of the company's shareholders. In the chart below, we zoom in on the different ownership groups of ClearView Wealth. Check out our latest analysis for ClearView Wealth What Does The Institutional Ownership Tell Us About ClearView Wealth? Institutions typically measure themselves against a benchmark when reporting to their own investors, so they often become more enthusiastic about a stock once it's included in a major index. We would expect most companies to have some institutions on the register, especially if they are growing. We can see that ClearView Wealth does have institutional investors; and they hold a good portion of the company's stock. This implies the analysts working for those institutions have looked at the stock and they like it. But just like anyone else, they could be wrong. When multiple institutions own a stock, there's always a risk that they are in a 'crowded trade'. When such a trade goes wrong, multiple parties may compete to sell stock fast. This risk is higher in a company without a history of growth. You can see ClearView Wealth's historic earnings and revenue below, but keep in mind there's always more to the story. ClearView Wealth is not owned by hedge funds. Crescent Capital Partners Management Pty Ltd. is currently the largest shareholder, with 35% of shares outstanding. In comparison, the second and third largest shareholders hold about 16% and 6.1% of the stock. To make our study more interesting, we found that the top 2 shareholders have a majority ownership in the company, meaning that they are powerful enough to influence the decisions of the company. Researching institutional ownership is a good way to gauge and filter a stock's expected performance. The same can be achieved by studying analyst sentiments. There is some analyst coverage of the stock, but it could still become more well known, with time. Insider Ownership Of ClearView Wealth The definition of an insider can differ slightly between different countries, but members of the board of directors always count. The company management answer to the board and the latter should represent the interests of shareholders. Notably, sometimes top-level managers are on the board themselves. Most consider insider ownership a positive because it can indicate the board is well aligned with other shareholders. However, on some occasions too much power is concentrated within this group. Shareholders would probably be interested to learn that insiders own shares in ClearView Wealth Limited. In their own names, insiders own AU$5.8m worth of stock in the AU$295m company. It is good to see some investment by insiders, but we usually like to see higher insider holdings. It might be worth checking if those insiders have been buying. General Public Ownership With a 32% ownership, the general public, mostly comprising of individual investors, have some degree of sway over ClearView Wealth. While this size of ownership may not be enough to sway a policy decision in their favour, they can still make a collective impact on company policies. Private Equity Ownership With a stake of 35%, private equity firms could influence the ClearView Wealth board. Sometimes we see private equity stick around for the long term, but generally speaking they have a shorter investment horizon and -- as the name suggests -- don't invest in public companies much. After some time they may look to sell and redeploy capital elsewhere. Next Steps: While it is well worth considering the different groups that own a company, there are other factors that are even more important. Take risks for example - ClearView Wealth has 1 warning sign we think you should be aware of. If you would prefer discover what analysts are predicting in terms of future growth, do not miss this free report on analyst forecasts. NB: Figures in this article are calculated using data from the last twelve months, which refer to the 12-month period ending on the last date of the month the financial statement is dated. This may not be consistent with full year annual report figures. Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Yahoo
3 hours ago
- Yahoo
3 ASX Penny Stocks With Over A$700M Market Cap
Australian shares recently made a strong push past the 8,800 level, marking a year-to-date increase of about 7%, though recent trading has seen some cautious selling. In this context, penny stocks—despite their somewhat outdated name—remain an intriguing area for investors seeking opportunities in smaller or newer companies. These stocks can offer surprising value and potential returns when backed by solid financial foundations, making them worth exploring for those interested in uncovering hidden gems within the market. Top 10 Penny Stocks In Australia Name Share Price Market Cap Financial Health Rating Alfabs Australia (ASX:AAL) A$0.40 A$114.64M ★★★★☆☆ EZZ Life Science Holdings (ASX:EZZ) A$2.36 A$111.33M ★★★★★★ GTN (ASX:GTN) A$0.375 A$71.5M ★★★★★★ IVE Group (ASX:IGL) A$2.90 A$447.13M ★★★★★☆ West African Resources (ASX:WAF) A$2.61 A$2.98B ★★★★★★ Southern Cross Electrical Engineering (ASX:SXE) A$1.82 A$481.22M ★★★★★★ Regal Partners (ASX:RPL) A$3.05 A$1.03B ★★★★★★ Austco Healthcare (ASX:AHC) A$0.385 A$140.68M ★★★★★★ CTI Logistics (ASX:CLX) A$1.85 A$149.01M ★★★★☆☆ Reckon (ASX:RKN) A$0.61 A$69.11M ★★★★☆☆ Click here to see the full list of 456 stocks from our ASX Penny Stocks screener. Let's explore several standout options from the results in the screener. Djerriwarrh Investments Simply Wall St Financial Health Rating: ★★★★★★ Overview: Djerriwarrh Investments Limited is a publicly owned investment manager with a market cap of A$862.81 million, focusing on managing investment portfolios. Operations: The company generates revenue primarily from its portfolio of investments, amounting to A$53.07 million. Market Cap: A$862.81M Djerriwarrh Investments Limited, with a market cap of A$862.81 million, is financially robust, as evidenced by its well-covered interest payments and operating cash flow exceeding debt. The company's seasoned management team and board of directors contribute to its stability. Despite earnings growth slowing to 0.6% over the past year compared to a 5-year average of 7.9%, Djerriwarrh maintains high-quality earnings and strong net profit margins at 73.8%. However, its dividend yield of 4.73% is not well covered by earnings or free cash flows, signaling potential sustainability concerns for income-focused investors. Get an in-depth perspective on Djerriwarrh Investments' performance by reading our balance sheet health report here. Examine Djerriwarrh Investments' past performance report to understand how it has performed in prior years. Kingsgate Consolidated Simply Wall St Financial Health Rating: ★★★★★☆ Overview: Kingsgate Consolidated Limited is involved in the exploration, development, and mining of gold and silver mineral properties, with a market cap of A$700.41 million. Operations: The company generates revenue primarily from its Chatree segment, amounting to A$210.69 million. Market Cap: A$700.41M Kingsgate Consolidated Limited, with a market cap of A$700.41 million, has demonstrated significant earnings growth of 1203% over the past year, far outpacing its industry peers. Despite this impressive growth and a strong return on equity of 74.4%, the company faces challenges such as short-term assets not covering long-term liabilities and recent executive changes with Mischa Mutavdzic appointed as CFO. While trading at a substantial discount to its estimated fair value, Kingsgate's debt management is commendable with well-covered interest payments and reduced net debt to equity ratio over time. Click here to discover the nuances of Kingsgate Consolidated with our detailed analytical financial health report. Gain insights into Kingsgate Consolidated's outlook and expected performance with our report on the company's earnings estimates. Regal Partners Simply Wall St Financial Health Rating: ★★★★★★ Overview: Regal Partners Limited is a privately owned hedge fund sponsor with a market cap of A$1.03 billion. Operations: The company generates revenue of A$257.55 million from its investment management services segment. Market Cap: A$1.03B Regal Partners Limited, with a market cap of A$1.03 billion, has shown remarkable earnings growth of 4050.4% over the past year, surpassing industry averages. The company is debt-free and trades below its estimated fair value by 25.2%, suggesting potential undervaluation compared to peers. Despite low return on equity at 7.8%, Regal maintains high-quality earnings and improved net profit margins from the previous year. Recent insider selling raises concerns; however, strong asset coverage for both short- and long-term liabilities provides financial stability. The company seeks strategic acquisitions to enhance shareholder value while maintaining disciplined M&A practices. Click to explore a detailed breakdown of our findings in Regal Partners' financial health report. Explore Regal Partners' analyst forecasts in our growth report. Seize The Opportunity Get an in-depth perspective on all 456 ASX Penny Stocks by using our screener here. Ready For A Different Approach? Find companies with promising cash flow potential yet trading below their fair value. This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Companies discussed in this article include ASX:DJW ASX:KCN and ASX:RPL. This article was originally published by Simply Wall St. Have feedback on this article? Concerned about the content? with us directly. Alternatively, email editorial-team@ Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
